World Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.33M Sell
16,936
-25
-0.1% -$12K 0.14% 169
2026
Q1
$8.34M Sell
16,961
-270
-2% -$147K 0.13% 180
2025
Q4
$9.98M Buy
17,231
+297
+2% +$168K 0.16% 145
2025
Q3
$8.21M Sell
16,934
-419
-2% -$195K 0.17% 139
2025
Q2
$7.04M Buy
17,353
+631
+4% +$264K 0.16% 153
2025
Q1
$8.32M Sell
16,722
-233
-1% -$126K 0.22% 111
2024
Q4
$8.82M Buy
16,955
+1,867
+12% +$1.03M 0.24% 94
2024
Q3
$9.33M Buy
15,088
+548
+4% +$324K 0.29% 81
2024
Q2
$8.04M Buy
14,540
+12,396
+578% +$7.1M 0.5% 45
2024
Q1
$3M Sell
2,144
-3,047
-59% -$1.71M 0.43% 55
2023
Q4
$2.76M Buy
+5,191
New +$2.51M 0.36% 63
2019
Q1
Sell
-959
Closed -$238K 161
2018
Q4
$238K Buy
+959
New +$225K 0.11% 128

Other funds holding TMO

World Investment Advisors's TMO Position: Q2 2026 in Review

World Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.15% in Q2 2026, selling an estimated $12K and leaving 16,936 shares worth $8.33M. The position accounts for 0.14% of the portfolio, ranked #169.

World Investment Advisors first reported a position in TMO in Q4 2018 and has held it in 12 quarters since. The position peaked at $9.98M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • World Investment Advisors held 16,936 shares of Thermo Fisher Scientific worth $8.33M as of Q2 2026.
  • World Investment Advisors sold 25 Thermo Fisher Scientific shares in Q2 2026, an estimated $12K.
  • Thermo Fisher Scientific made up 0.14% of World Investment Advisors's portfolio in Q2 2026, its #169 holding.
  • World Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 12 quarters since.
  • World Investment Advisors's Thermo Fisher Scientific position peaked at $9.98M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.